Latent Class Analysis: An innovative approach for identification of clinical and laboratory markers of disease severity among COVID-19 patients admitted to the Intensive Care Unit.
IJID REGIONS (ONLINE) 2022;
5:154-162. [PMID:
36339932 PMCID:
PMC9622019 DOI:
10.1016/j.ijregi.2022.10.004]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/15/2022] [Revised: 10/13/2022] [Accepted: 10/17/2022] [Indexed: 11/17/2022]
Abstract
Objective
To identify clinical and laboratory phenotype distribution patterns and their usefulness as prognostic markers in COVID-19 patients admitted to the intensive care unit (ICU) in Tygerberg Hospital, Cape Town.
Methods and Results
We used a latent class analysis (LCA) model in a prospective, observational cohort study. Data from 343 COVID-19 patients was analysed. Two distinct phenotypes 1 and 2, comprising 68.46 % and 31.54% patients respectively, were identified. The phenotype 2 patients were characterised by increased coagulopathy markers (D-dimer, median value 1.73 ng/L vs 0.94 ng/L, p <0.001), end-organ dysfunction (creatinine, median 79 µmol/L vs 69.5 µmol/L, p <0.003), under-perfusion marker (lactate, median value 1.60 mmol/L, vs 1.20 mmol/L, p <0.001), abnormal cardiac function markers (median N-terminal pro-brain natriuretic peptide (NT-proBNP) 314 pg/ml vs 63.5 pg/ml, p <0.001 and median high-sensitivity cardiac troponin (Hs-TropT) 39 ng/l vs 12 ng/ l, p<0.001) and acute inflammatory syndrome (median neutrophil-to-lymphocyte ratio 15.08 vs value 8.68, p <0.001 and monocyte, median value 0.68 × 109/L vs 0.45 × 109/L, p <0.001).
Conclusion
The identification of COVID-19 phenotypes and sub-phenotypes in ICU patients could help as prognostic markers in day-to-day management of COVID-19 patients admitted to the ICU.
Collapse